NSEAnalysts/Institutional Investor Meet/Con. Call Updates7 Aug 2026 · 7 Aug 2026, 04:56 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Epigral Limited · EPIGRAL
✦ AI Summary
Epigral Limited has informed the Exchange about participation in EMKAY Confluence 2026 on 12th August, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Epigral Limited has informed the Exchange about participation in EMKAY Confluence 2026 on 12th August, 2026
Attachments (1)
📄pdf
Download →
MFL_07082026165527_Conference.pdf
View document text
07.08.2026
National Stock Exchange of India Limited BSE Limited
“Exchange Plaza”, Floor- 25, P J Tower,
Bandra-Kurla Complex, Dalal Street,
Bandra (East) Mumbai 400 051 Mumbai 400 001
SCRIP CODE: EPIGRAL SCRIP CODE: 543332
Dear Sir/s,
Sub: Intimation of Participation in EMKAY Confluence 2026
Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, Epigral Limited (“the Company”) hereby informs
that the officials of the Company are participating in the following conference:
Name EMKAY Confluence 2026
Date Wednesday, 12th August, 2026
Location Mumbai
We request you to take note of the above and place it for information of members.
Thanking you,
Yours faithfully,
For Epigral Limited
Gaurang Trivedi
Company Secretary & Compliance Officer
M. No. A22307